[HTML][HTML] Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review

AM Hashem, BS Alghamdi, AA Algaissi… - Travel medicine and …, 2020 - Elsevier
Abstract The rapidly spreading Coronavirus Disease (COVID-19) pandemic, caused by the
severe acute respiratory syndrome coronavirus (SARS-CoV-2), represents an …

Effects of chloroquine on viral infections: an old drug against today's diseases

A Savarino, JR Boelaert, A Cassone… - The Lancet infectious …, 2003 - thelancet.com
Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial
effects, the drug has interesting biochemical properties that might be applied against some …

[HTML][HTML] Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models

R Delvecchio, LM Higa, P Pezzuto, AL Valadão… - Viruses, 2016 - mdpi.com
Zika virus (ZIKV) infection in utero might lead to microcephaly and other congenital defects.
Since no specific therapy is available thus far, there is an urgent need for the discovery of …

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century

JM Rolain, P Colson, D Raoult - International journal of antimicrobial agents, 2007 - Elsevier
Chloroquine (CQ) and its hydroxyl analogue hydroxychloroquine (HCQ) are weak bases
with a half-century long use as antimalarial agents. Apart from this antimalarial activity, CQ …

The SARS-CoV-2 cytopathic effect is blocked by lysosome alkalizing small molecules

K Gorshkov, CZ Chen, R Bostwick… - ACS infectious …, 2020 - ACS Publications
Understanding the SARS-CoV-2 virus' pathways of infection, virus–host–protein interactions,
and mechanisms of virus-induced cytopathic effects will greatly aid in the discovery and …

Pyridine and pyrimidine derivatives as privileged scaffolds in biologically active agents

MA Chiacchio, D Iannazzo, R Romeo… - Current medicinal …, 2019 - ingentaconnect.com
Pyridine and pyrimidine derivatives have received great interest in recent pharmacological
research, being effective in the treatment of various malignancies, such as myeloid …

A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?

TJ Oscanoa, R Romero-Ortuno, A Carvajal… - International journal of …, 2020 - Elsevier
ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is having serious consequences on …

[HTML][HTML] The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators

K Gorshkov, CZ Chen, R Bostwick, L Rasmussen, M Xu… - Biorxiv, 2020 - ncbi.nlm.nih.gov
SARS-CoV-02 is a new type of coronavirus capable of rapid transmission and causing
severe clinical symptoms; much of which has unknown biological etiology. It has prompted …

Insights of severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic: a current review

J Choudhary, S Dheeman, V Sharma, P Katiyar… - Biological procedures …, 2021 - Springer
COVID-19, a pandemic of the 21st century caused by novel coronavirus SARS-CoV-2 was
originated from China and shallowed world economy and human resource. The medical …

Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein

S Ozden, M Lucas-Hourani, PE Ceccaldi… - Journal of Biological …, 2008 - ASBMB
Chikungunya virus (CHIKV) is a mosquito-transmitted Alphavirus that causes in humans an
acute infection characterized by polyarthralgia, fever, myalgia, and headache. Since 2005 …